Skip to content
NBDC Human Database

No datasets in the cart.

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000635

Type of data
NGS (RNA-seq)
Access criteria
Controlled-access (Type I)
Total data volume
2.7 TB
File formats
  • FASTQ
Research
hum0182
Date published
2022-05-23
Date modified
2022-05-23

Analysis method

RNA-seq

Materials and participants
HCC (ICD10: C22.0): 42 cases
tumor liver tissues: 42 samples
matched non-tumor liver tissues: 42 samples
Breast cancer cell line (MCF-7): 1 sample
  • Health status
    Affected
  • Subject count
    42 (Individual)
Disease
HCC (C220)
Sample description
RNAs derived from tumor and matched non-tumor liver tissues and breast cancer cell line
  • Tumor / normal
    Mixed
Cell line
MCF-7
Sample provider
MCF-7; RNA was purchased from Cosmo Bio Co., Ltd.
Experimental method
RNA-seq
Target
N/A
Reagent kit
Ligation Sequencing Kit (SQK-LSK109)
Fragmentation
N/A
Platform
Oxford Nanopore Technologies MinION
Read type
Single-end
Read length
1411.4 bp